Table 1.
Participants’ characteristics at baseline (2003–2006) and follow-up 1 (2009–2012).
| Baseline (2003–2006) | Follow-up 1 (2009–2012) | |
|---|---|---|
| N | 6203 | 4206 |
| Follow-up duration [years], median (IQR) | 10 (6–10) | 9 (5–9) |
| Male sex, n (%) | 2861 (46) | 1867 (44) |
| Age [years], mean ± SD | 52 ± 11 | 58 ± 10 |
| Current smoker, n (%) | 1670 (27) | 919 (22) |
| Blood pressure [mmHg], mean ± SD | ||
| Systolic | 128 ± 18 | 126 ± 18 |
| Diastolic | 79 ± 11 | 78 ± 11 |
| Total cholestérol [mmol/L], mean ± SD | 5.6 ± 1 | 5.7 ± 1 |
| Hdl-cholestérol [mmol/L], mean ± SD | 1.6 ± 0.4 | 1.6 ± 0.5 |
| Ldl-cholestérol [mmol/L], mean ± SD | 3.3 ± 1 | 3.5 ± 1 |
| Hypertension, n (%) | 2220 (36) | 1666 (40) |
| Diabetes, n (%) | 351 (6) | 416 (10) |
| Chronic kidney disease, n (%) | 262 (4) | 266 (6) |
| Lipid modifying agents, n (%) | 678 (11) | 693 (16) |
| Antihypertensive agents, n (%) | 1107 (18) | 1048 (25) |
Description with mean and SD of variables showing a normal distribution and using median, and interquartile range for skewed variables. SDa, standard deviation; IQR, interquartile range; n, number.